Published in Eur J Immunol on October 01, 1999
Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog (2008) 1.94
Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists. J Exp Med (2003) 1.70
A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells. Oncogene (2003) 1.54
c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells. Blood (2005) 1.36
Targeting antiapoptotic A1/Bfl-1 by in vivo RNAi reveals multiple roles in leukocyte development in mice. Blood (2012) 1.25
Sumoylation of the transcription factor NFATc1 leads to its subnuclear relocalization and interleukin-2 repression by histone deacetylase. J Biol Chem (2009) 1.13
Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Br J Cancer (2007) 1.05
The essential role of evasion from cell death in cancer. Adv Cancer Res (2011) 1.05
Bcl-2-regulated cell death signalling in the prevention of autoimmunity. Cell Death Dis (2010) 1.04
A1/Bfl-1 in leukocyte development and cell death. Exp Cell Res (2012) 0.97
The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells. Br J Haematol (2004) 0.96
Regulation of memory B-cell survival by the BH3-only protein Puma. Blood (2011) 0.93
Vγ9 and Vδ2 T cell antigen receptor genes and butyrophilin 3 (BTN3) emerged with placental mammals and are concomitantly preserved in selected species like alpaca (Vicugna pacos). Immunogenetics (2014) 0.86
The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation. J Virol (2015) 0.80
Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival. Cell Death Differ (2015) 0.80
Co-expression of sCD40LIg and CTLA4Ig mediated by adenovirus prolonged mouse skin allograft survival. J Zhejiang Univ Sci B (2006) 0.79
Superantigen-presentation by rat major histocompatibility complex class II molecules RT1.Bl and RT1.Dl. Immunology (2008) 0.75
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell (1993) 11.95
Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature (1991) 5.51
Replacement of T-cell function by a T-cell product. Nat New Biol (1972) 5.20
Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity (1999) 3.69
Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol (1997) 2.42
Foamy virus capsids require the cognate envelope protein for particle export. J Virol (1999) 2.30
Foamy virus particle formation. J Virol (1998) 2.22
A third signal in B cell activation given by TRF. Transplant Rev (1975) 2.18
Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem (2001) 1.92
Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med (1995) 1.70
Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur J Immunol (1995) 1.62
Stimulation of IgG antibody response in vitro by T cell-replacing factor. J Exp Med (1973) 1.55
Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol (2001) 1.55
The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J Exp Med (1997) 1.55
The role of NF-AT transcription factors in T cell activation and differentiation. Biochim Biophys Acta (2000) 1.54
Inhibition of in vitro immune response by treatment of spleen cell suspensions with anti-theta serum. Nature (1970) 1.53
Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep (2001) 1.51
Reconstitution of a thymus cell-deprived immune system by syngeneic and allogeneic thymocytes in vitro. Eur J Immunol (1971) 1.47
Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors. J Virol (1998) 1.46
Cyanamide Formation under Primitive Earth Conditions. Science (1965) 1.42
RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J (1995) 1.34
The differentiation function of T cell-replacing factor in nu-nu spleen cell cultures. Eur J Immunol (1974) 1.33
An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J Virol (2000) 1.23
Autoradiographic studies on the proliferation of antibody-producing cells in vitro. J Exp Med (1974) 1.20
Partial characterization and purification of murine T cell-replacing factor, TRF. II. Biochemical characteristics. Immunochemistry (1978) 1.20
Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes. Proc Natl Acad Sci U S A (1987) 1.18
Expression of MuLV GP71-like antigen in normal mouse spleen cells induced by antigenic stimulation. Nature (1977) 1.18
Cells expressing the human foamy virus (HFV) accessory Bet protein are resistant to productive HFV superinfection. Virology (1998) 1.16
Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals. Mol Cell Biol (2001) 1.16
Studies on the generation and expression of H-2-controlled T helper function in chimeric mice: evidence for two levels of H-2 resitriction. Eur J Immunol (1979) 1.16
Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol (1997) 1.15
Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control. Oncogene (2001) 1.13
Efficient intracellular retrotransposition of an exogenous primate retrovirus genome. EMBO J (2000) 1.11
Evidence for an excess of B→D*τ(-)ν(τ) decays. Phys Rev Lett (2012) 1.10
A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol (1996) 1.09
Observation of time-reversal violation in the B0 meson system. Phys Rev Lett (2012) 1.09
Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes. J Immunol (1999) 1.08
The interleukin 2 receptor alpha chain/CD25 promoter is a target for nuclear factor of activated T cells. J Exp Med (1998) 1.07
Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice. Eur J Immunol (1998) 1.07
Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab')2-co-stimulated B lymphocytes. Eur J Immunol (1996) 1.07
Action of dextran sulfate as a direct and general B cell mitogen. Eur J Immunol (1974) 1.07
Inducible nuclear factors binding the IgM heavy chain pre-mRNA secretory poly(A) site. Eur J Immunol (1996) 1.05
Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor. EMBO J (2001) 1.05
Downregulation of HLA class I antigens in HIV-1-infected cells. AIDS Res Hum Retroviruses (1989) 1.05
Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med (1997) 1.04
CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB. J Immunol (1996) 1.01
NF-ATp plays a prominent role in the transcriptional induction of Th2-type lymphokines. Immunol Lett (1997) 1.01
Stimulation of murine B cells with anti-Ig antibodies: dominance of a negative signal mediated by the Fc receptor. Eur J Immunol (1980) 1.00
Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression. Eur J Immunol (1987) 1.00
Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol (2001) 0.99
Transcriptional control of mu- and kappa-gene expression in resting and bacterial lipopolysaccharide-activated normal B cells. Immunobiology (1987) 0.98
Recognition of apoptotic cells by macrophages activates the peroxisome proliferator-activated receptor-gamma and attenuates the oxidative burst. Cell Death Differ (2005) 0.98
Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells. Eur J Immunol (1997) 0.98
Thymic selection and peptide-induced activation of T cell receptor-transgenic CD8 T cells in interleukin-2-deficient mice. Eur J Immunol (1994) 0.97
Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching. Eur J Immunol (2001) 0.94
Studies on the source and action of the T-cell replacing factor (TRF). Adv Exp Med Biol (1973) 0.94
IgM RNA switch from membrane to secretory form is prevented by adding antireceptor antibody to bacterial lipopolysaccharide-stimulated murine primary B-cell cultures. Proc Natl Acad Sci U S A (1985) 0.94
The role of accessory cells in polyclonal T cell activation. I. Both induction of interleukin 2 production and of interleukin 2 responsiveness by concanavalin A are accessory cell dependent. Eur J Immunol (1983) 0.94
T cell subset distribution and B cell hyperreactivity in mice expressing interleukin-4 under the control of major histocompatibility complex class I regulatory sequences. Eur J Immunol (1994) 0.93
C/EBPbeta enhances IL-4 but impairs IL-2 and IFN-gamma induction in T cells. Eur J Immunol (2000) 0.92
Regulation of IL 2 expression in mitogen-activated murine T lymphocytes. Immunobiology (1987) 0.92
Early phenotypic and functional alterations in lymphocytes from simian immunodeficiency virus infected macaques. Vet Immunol Immunopathol (1993) 0.90
Self-reported exercise before age 40: influence on quantitative skeletal ultrasound and fall risk in the elderly. Arch Phys Med Rehabil (2001) 0.90
Reversal of Blimp-1-mediated apoptosis by A1, a member of the Bcl-2 family. Eur J Immunol (1999) 0.89
A T-cell -produced mediator substance active in the humoral immune response. Ann N Y Acad Sci (1975) 0.89
Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity. Virus Res (1990) 0.89
Overexpression of the antiapoptotic protein A1 promotes the survival of double positive thymocytes awaiting positive selection. Cell Death Differ (2005) 0.88
In vitro immunization of naive mouse B cells: establishment of IgM secreting hybridomas specific for souble protein or hapten from B cells cultured on CD40 ligand transfected mouse fibroblasts. Int Immunol (1996) 0.86
HIV type 1 abrogates TAP-mediated transport of antigenic peptides presented by MHC class I. Transporter associated with antigen presentation. AIDS Res Hum Retroviruses (2002) 0.83
Regulation of lymphokine expression in T cell activation. I. Rapid loss of interleukin-specific RNA after removal of the stimulating signal. Eur J Immunol (1991) 0.83
Impaired survival of T cell receptor V gamma 3+ cells in interleukin-4 transgenic mice. Eur J Immunol (1995) 0.82
Tracking image correlation: combining single-particle tracking and image correlation. Biophys J (2013) 0.82
Foamy virus--adenovirus hybrid vectors. Gene Ther (2004) 0.82
Regulation of Ig gene expression in normal lymphocytes. I. The half-life of secreted mu chain mRNA differs from that of membrane mu chain mRNA in resting and activated B cells. Eur J Immunol (1990) 0.82
Efficient transduction and long-term retroviral expression of the melanoma-associated tumor antigen tyrosinase in CD34(+) cord blood-derived dendritic cells. Gene Ther (2002) 0.80
Systemic autoimmune disease as a consequence of defective lymphocyte death. Curr Opin Immunol (1997) 0.80
Regulation of immunoglobulin gene expression in normal lymphocytes. II. Mechanisms of down-regulation of immunoglobulin secretion after engagement of the B cell antigen receptor. Eur J Immunol (1992) 0.80
Expression of endogenous retroviral glycoprotein 70 by antigen-activated cytotoxic and suppressor T lymphocytes of nice. Proc Natl Acad Sci U S A (1982) 0.79
Inefficient termination of antigen responses in NF-ATp-deficient mice. Immunobiology (1997) 0.79
Time course of lectin and storage protein biosynthesis in developing pea (Pisum sativum) seeds. Biol Chem Hoppe Seyler (1993) 0.78
The CD40 TRAF family member interacting motif carries the information to rescue WEHI 231 cells from anti-IGM-induced growth arrest. Eur J Immunol (1998) 0.78
Kinetics of cellular oncogene expression in mouse lymphocytes. I. Expression of c-myc and c-ras-Ha in T lymphocytes induced by various mitogens. Eur J Immunol (1986) 0.78
CD40 and its ligand in the regulation of humoral immunity. Semin Immunol (1994) 0.78
Lymphokines active in B cell proliferation and differentiation. Springer Semin Immunopathol (1984) 0.77
The mitochondrial protein TCAIM regulates activation of T cells and thereby promotes tolerance induction of allogeneic transplants. Am J Transplant (2014) 0.77
Quantitative and qualitative differences in IL-2 and IL-4 expression in primary and secondary T cell stimulation. Int Immunol (1992) 0.77
Mechanism of MHC class I downregulation in HIV infected cells. Immunobiology (1992) 0.77